ReviewInternational urology and nephrology2026
Sound therapy in renal disease management: a narrative review by the Kasr Al-Ainy Nephrology Group (KANG).
Review in International urology and nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSound therapy, a non-invasive practice using auditory stimuli such as music, tones, or specific frequencies, has demonstrated physiological and psychological benefits in neurology, pain management, and mental health. Its application in renal disease management, however, is still emerging.
objectiveTo summarize current knowledge regarding the potential effects of sound therapy on kidney diseases-including chronic kidney disease (CKD), acute kidney injury (AKI), dialysis, and kidney transplantation-and to highlight directions for future research.
methodsThe Kasr Al-Ainy Nephrology Group (KANG) conducted a comprehensive narrative review with systematic search methodology in PubMed and major databases up to 2025. Search terms included "sound therapy," "music therapy," "vibroacoustic therapy," and "renal disease." Eligible studies comprised animal experiments, clinical trials, and observational studies reporting renal or symptom-related outcomes. This review examines both auditory interventions (music therapy, vibroacoustic therapy) and mechanical modalities (therapeutic ultrasound), acknowledging their distinct mechanisms. Evidence quality is generally low to moderate.
resultsProposed mechanisms of benefit include stress reduction, autonomic regulation, blood pressure (BP) modulation, and improved microcirculation. Animal studies suggest renal protective effects, while small human trials in hemodialysis patients report reductions in anxiety, pain, and BP. Evidence in peritoneal dialysis and transplantation remains scarce. Vibroacoustic and frequency-specific sound stimulation appear promising but are insufficiently studied.
conclusionPreliminary evidence indicates that sound therapy may improve comfort and psychological well-being in renal patients, with possible physiological benefits. However, the evidence base is weak. Large, well-designed, multidisciplinary trials are required to establish efficacy, optimize protocols, and assess safety before integration into routine nephrology care.
Indexed as
Identifiers
41739358What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.